Target intelligence / Profile preview

Reactive carbonyl compounds, oxygen-centered radicals, and catalytic metal ions (RCCs, ROS, and metal ions)

Target
RCCs, ROS, and metal ions
Molecular classification
Reactive species, Transition metals, Electrophiles, Pro-oxidants
01

Overview

This target profile describes a complex of reactive chemical species and catalysts—specifically reactive carbonyl compounds (RCCs), oxygen-centered radicals (ROS), and catalytic transition metal ions—that collectively drive the progression of oxidative and carbonyl stress [1]. RCCs like methylglyoxal and malondialdehyde are potent electrophiles that modify proteins to form advanced glycation end-products (AGEs), while oxygen-centered radicals like the hydroxyl radical cause direct oxidative damage to DNA and lipids [2, 3]. Catalytic metal ions, such as iron and copper, act as essential cofactors that amplify this damage by facilitating the production of radicals through Fenton and Haber-Weiss chemistry [4]. While not a single protein target, this chemical network is a major therapeutic focus in metabolic and neurodegenerative diseases, where drugs like aminoguanidine and pyridoxamine are designed to scavenge these reactive intermediates or chelate the metal catalysts [5, 6]. Targeting this system aims to prevent the irreversible cross-linking of proteins and the inflammatory signaling cascades triggered by oxidative damage.

Other names
Carbonyl stress factorsOxidative stress mediatorsPro-oxidantsReactive species and metal catalystsGlycoxidation mediators
02

Mechanism of action

Scavenging of electrophilic carbonyls, neutralization of free radicals, and chelation of redox-active metal ions to prevent the formation of advanced glycation end-products and oxidative cellular damage.

03

Biological functions

Oxidative stressCarbonyl stressLipid peroxidationProtein glycationMetal homeostasisRedox signaling
04

Disease associations

Diabetes mellitusAlzheimer's diseaseAtherosclerosisChronic kidney diseaseNeurodegenerative diseaseAging
05

Safety considerations

Interference with essential physiological redox signalingPotential systemic toxicity of metal chelatorsLack of specificity in scavengingPoor clinical translation of broad-spectrum antioxidants
06

Interacting drugs

Aminoguanidine

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonyl contentPentosidineCarboxymethyllysine (CML)Nitrotyrosine

Beyond the preview

Go deeper on Reactive carbonyl compounds, oxygen-centered radicals, and catalytic metal ions (RCCs, ROS, and metal ions).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive carbonyl compounds, oxygen-centered radicals, and catalytic metal ions (RCCs, ROS, and metal ions).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call